Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Ottolander, J. Gratama, J. Koning, A. Brand (2009)
Long-term follow-up study of 168 patients with immune thrombocytopenia. Implications for therapy.Scandinavian journal of haematology, 32 1
S. Strother, K. Zuckerman, A. Lobuglio (1984)
Colchicine therapy for refractory idiopathic thrombocytopenic purpura.Archives of internal medicine, 144 11
M. Kuwana, J. Kaburaki, Yasuo Ikeda (1998)
Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.The Journal of clinical investigation, 102 7
A. Newland, M. Caulier, M. Schipperus, M. Kappers‐Klunne, B. Varet, K. Watkins, Chien-Feng Chen, J. Nichol (2004)
An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP).Blood, 104
Lei Zhang, Hong-qiang Li, Hui Zhao, L. Ji, R. Yang (2003)
Hepatitis C virus‐related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese centerEuropean Journal of Haematology, 70
M. Narita, Masuhiro Takahashi, I. Fuse, Yoshihusa Aizawa (2003)
Ca2+ ionophore‐induced dendritic cell differentiation in a patient with defective Ca2+ ionophore‐induced platelet aggregationBritish Journal of Haematology, 120
R. Burrows, J. Kelton (1993)
Pregnancy in Patients With Idiopathic Thrombocytopenic Purpura: Assessing the Risks for the Infant at DeliveryObstetrical & Gynecological Survey, 48
M. Baumann, J. Menitove, R. Aster, T. Anderson (1986)
Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion.Annals of internal medicine, 104 6
N. Cooper, N. Heddle, M. Haas, M. Reid, M. Lesser, H. Fleit, B. Woloski, J. Bussel (2004)
Intravenous (IV) anti‐D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti‐D by FcγRIIa and FcγRIIIa polymorphismsBritish Journal of Haematology, 124
A. Gaines (2000)
Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.Blood, 95 8
A. Halhali, S. Wimalawansa, VERONICA BERENTSEN, E. Avila, C. Thota, F. Larrea (2001)
Calcitonin Gene‐ and Parathyroid Hormone‐Related Peptides in Preeclampsia: Effects of Magnesium SulfateObstetrics & Gynecology, 97
K. Webert, R. Mittal, C. Sigouin, N. Heddle, J. Kelton (2003)
A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura.Blood, 102 13
D. Stoll, D. Cines, R. Aster, S. Murphy (1985)
Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia.Blood, 65 3
G. Emilia, Giuseppe Longo, M. Luppi, G. Gandini, M. Morselli, L. Ferrara, S. Amarri, K. Cagossi, G. Torelli (2001)
Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura.Blood, 97 3
R. Mcmillan, Lei Wang, P. Tani (2003)
Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP)Journal of Thrombosis and Haemostasis, 1
A. Borne, J. Vos, J. Pegels, L. Thomas, van Lelie (1988)
High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopeniaBritish Medical Journal (Clinical research ed.), 296
R. Mcmillan (1997)
Therapy for Adults with Refractory Chronic Immune Thrombocytopenic PurpuraAnnals of Internal Medicine, 126
K. Gill, J. Kelton (2000)
Management of idiopathic thrombocytopenic purpura in pregnancy.Seminars in hematology, 37 3
Y. Ahn, R. Rocha, R. Mylvaganam, Rolando Garcia, R. Duncan, W. Harrington (1989)
Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women.Annals of internal medicine, 111 9
R. Huhn, P. Fogarty, R. Nakamura, E. Read, S. Leitman, M. Rick, Janice Kimball, A. Greene, K. Hansmann, A. Gratwohl, N. Young, A. Barrett, C. Dunbar (2003)
High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia.Blood, 101 1
M. Michel, M. Novoa, J. Bussel (2003)
Intravenous anti‐D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancyBritish Journal of Haematology, 123
Yunfeng Cheng, R. Wong, Y. Soo, C. Chui, F. Lau, N. Chan, W. Wong, G. Cheng (2003)
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.The New England journal of medicine, 349 9
S. Vesely, Jedidiah Perdue, M. Rizvi, Deirdra Terrell, J. George (2004)
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following SplenectomyAnnals of Internal Medicine, 140
S. Nomura, K. Dan, T. Hotta, K. Fujimura, Y. Ikeda (2002)
Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura.Blood, 100 2
G. Christiaens, H. Nieuwenhuis, J. Bussel (1997)
Comparison of Platelet Counts in First and Second Newborns of Mothers With Immune Thrombocytopenic PurpuraObstetrics & Gynecology, 90
R. Emmons, D. Reid, R. Cohen, G. Meng, N. Young, C. Dunbar, N. Shulman (1996)
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.Blood, 87 10
F. Radaelli, Paola Faccini, M. Goldaniga, E. Guggiari, E. Pozzoli, Teresa Maiolo, A. Ciani, E. Pogliani (2000)
Factors predicting response to splenectomy in adult patients with idiopathic thrombocytopenic purpura.Haematologica, 85 10
R. Mcmillan, Carol Durette (2004)
Long-term outcomes in adults with chronic ITP after splenectomy failure.Blood, 104 4
P. Berchtold, Robert Mcmiiian (1989)
Therapy of chronic idiopathic thrombocytopenic purpura in adults.Blood, 74 7
K. Kohda, T. Kuga, K. Kogawa, Yuuji Kanisawa, K. Koike, G. Kuroiwa, Y. Hirayama, Y. Sato, Y. Niitsu (2002)
Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpuraBritish Journal of Haematology, 118
G. Newman, M. Novoa, E. Fodero, M. Lesser, B. Woloski, J. Bussel (2001)
A dose of 75 μg/kg/d of i.v. anti‐D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpuraBritish Journal of Haematology, 112
J. Abramson, C. Baker, M. Fisher, M. Gerber, H. Meissner, D. Murray, G. Overturf, C. Prober, M. Rennels, T. Saari, L. Weiner, R. Whitley, G. Peter, L. Pickering, N. MacDonald, L. Chilton, G. Delage, S. Dowell, R. Jacobs, M. Myers, W. Orenstein, P. Patriarca, E. Ledbetter, J. Kim (2000)
Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic ProphylaxisPediatrics, 106
M. Kuwana, Y. Okazaki, J. Kaburaki, Y. Kawakami, Y. Ikeda (2002)
Spleen Is a Primary Site for Activation of Platelet-Reactive T and B Cells in Patients with Immune Thrombocytopenic Purpura1The Journal of Immunology, 168
P. Andersson, Anna Olsson, H. Wadenvik (2002)
Reduced transforming growth factor‐β1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpuraBritish Journal of Haematology, 116
K. McCrae, P. Samuels, A. Schreiber (1992)
Pregnancy-associated thrombocytopenia: pathogenesis and management.Blood, 80 11
M. Michel, N. Cooper, C. Jean, C. Frissora, J. Bussel (2004)
Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?Blood, 103 3
R. Stasi, E. Stipa, M. Masi, M. Cecconi, M. Scimo, Felicia Oliva, A. Sciarra, A. Perrotti, Gaspare Adomo, S. Amadori, G. Papa (1995)
Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.The American journal of medicine, 98 5
R. Diz‐Kucukkaya, A. Hacıhanefioğlu, M. Yenerel, M. Turgut, H. Keskin, M. Nalçacı, M. Inanç (2001)
Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.Blood, 98 6
C. Doan, B. Bouroncle, B. Wiseman (1960)
IDIOPATHIC AND SECONDARY THROMBOCYTOPENIC PURPURA: CLINICAL STUDY AND EVALUATION OF 381 CASES OVER A PERIOD OF 28 YEARSAnnals of Internal Medicine, 53
E. Bourgeois, M. Caulier, C. Delarozee, M. Brouillard, F. Bauters, P. Fenaux (2003)
Long‐term follow‐up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysisBritish Journal of Haematology, 120
N. Bizzaro (1995)
EDTA‐dependent pseudothrombocytopenia: A clinical and epidemiological study of 112 cases, with 10‐year follow‐upAmerican Journal of Hematology, 50
P. Berchtold, D. Mu¨ller, D. Beardsley, K. Fujisawa, C. Kaplan, R. Kekoma¨ki, E. Lipp, M. Morell-Kopp, V. Kiefel, R. Mcmillan, A. Borne, P. Imbach (1997)
International study to compare antigen‐specific methods used for the measurement of antiplatelet autoantibodiesBritish Journal of Haematology, 96
J. George, S. Woolf, G. Raskob, J. Wasser, L. Aledort, P. Ballem, V. Blanchette, J. Bussel, D. Cines, J. Kelton, A. Lichtin, R. Mcmillan, J. Okerbloom, D. Regan, I. Warrier (1996)
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.Blood, 88 1
M. Caulier, C. Rose, Marie Roussel, Claude Huart, F. Bauters, P. Fenaux (1995)
Pulsed high‐dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 casesBritish Journal of Haematology, 91
A. Neylon, P. Saunders, M. Howard, S. Proctor, P. Taylor (2003)
Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patientsBritish Journal of Haematology, 122
Y. Najean, J. Rain, C. Billotey (1997)
The site of destruction of autologous 111In‐labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomiesBritish Journal of Haematology, 97
P. du, P. Badenhorst, Lötter Mg, H. Pieters, P. Wessels, H. Kotze (1986)
Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ.Blood, 67 1
M. Kuwana, Y. Kawakami, Y. Ikeda (2003)
Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction: implications for treatment of immune thrombocytopenic purpura.Blood, 101 2
T. Brighton, S. Evans, P. Castaldi, C. Chesterman, B. Chong (1996)
Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias.Blood, 88 1
S. Difino, N. Lachant, J. Kirshner, A. Gottlieb (1980)
Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy.The American journal of medicine, 69 3
A. Mouzaki, M. Theodoropoulou, Ioannis Gianakopoulos, Vassiliki Vlaha, M. Kyrtsonis, A. Maniatis (2002)
Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis.Blood, 100 5
D. Provan, A. Newland, D. Norfolk, P. Bolton-Maggs, J. Lilleyman, I. Greer, A. May, M. Murphy, W. Ouwehand, S. Watson, Haematology Bcs. (2003)
Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancyBritish Journal of Haematology, 120
F. Fabris, T. Tassan, R. Ramon, G. Carraro, M. Randi, G. Luzzatto, P. Moschino, A. Girolami (2001)
Age as the major predictive factor of long‐term response to splenectomy in immune thrombocytopenic purpuraBritish Journal of Haematology, 112
M. Kappers‐Klunne, M. Veer (2001)
Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomyBritish Journal of Haematology, 114
Alexander Reiner, T. Gernsheimer, S. Slichter (1995)
Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura.Blood, 85 2
J. Howard, A. Hoffbrand, H. Prentice, A. Mehta (2002)
Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpuraBritish Journal of Haematology, 117
R. Burrows, J. Kelton (1993)
Fetal thrombocytopenia and its relation to maternal thrombocytopenia.The New England journal of medicine, 329 20
S. Payne, R. Resnik, T. Moore, H. Hedriana, T. Kelly (1997)
Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia.American journal of obstetrics and gynecology, 177 1
E. Letsky, M. Greaves (1996)
Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology.British journal of haematology, 95 1
R. Mcmillan (2000)
Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura.Seminars in hematology, 37 3
R. Mcmillan, Lei Wang, A. Tomer, J. Nichol, J. Pistillo (2004)
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.Blood, 103 4
D. Cines, V. Blanchette (2002)
Immune thrombocytopenic purpura.The New England journal of medicine, 346 13
J. Lortan (1993)
MANAGEMENT OF ASPLENIC PATIENTSBritish Journal of Haematology, 84
M. Marcaccio, M. Marcaccio (2000)
Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura.Seminars in hematology, 37 3
H. Frederiksen, K. Schmidt (1999)
The incidence of idiopathic thrombocytopenic purpura in adults increases with age.Blood, 94 3
D. Calverley, Glenn Jones, J. Kelton (1992)
Splenic radiation for corticosteroid-resistant immune thrombocytopenia.Annals of internal medicine, 116 12 Pt 1
Y. Beilin, J. Zahn, Michele Comerford (1997)
Safe Epidural Analgesia in Thirty Parturients with Platelet Counts Between 69,000 and 98,000 mm-3Anesthesia & Analgesia, 85
R. Mcmillan (2001)
Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.The New England journal of medicine, 344 18
B. Olsson, P. Andersson, M. Jernås, S. Jacobsson, B. Carlsson, L. Carlsson, H. Wadenvik (2003)
T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpuraNature Medicine, 9
A. Scaradavou, B. Woo, B. Woloski, S. Cunningham‐Rundles, L. Ettinger, L. Aledort, J. Bussel (1997)
Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 PatientsBlood, 89
J. Bartholomew, R. Salgia, W. Bell (1989)
Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid.Archives of internal medicine, 149 9
H. Deckmyn, S. Reys (1995)
Functional Effects of Human Antiplatelet AntibodiesSeminars in Thrombosis and Hemostatis, 21
J. Doweiko (2003)
Chapter 22 – Hematologic Manifestations of HIV Infection
J. Semple, Y. Milev, D. Cosgrave, M. Mody, A. Hornstein, V. Blanchette, J. Freedman (1996)
Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity.Blood, 87 10
J. Drachman (2004)
Inherited thrombocytopenia: when a low platelet count does not mean ITP.Blood, 103 2
M. Figueroa, J. Gehlsen, D. Hammond, S. Ondreyco, L. Piro, Talisman Pomeroy, Frederick Williams, R. Mcmillan (1993)
Combination chemotherapy in refractory immune thrombocytopenic purpura.The New England journal of medicine, 328 17
N. Cooper, B. Woloski, E. Fodero, M. Novoa, Melissa Leber, J. Beer, J. Bussel (2002)
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?Blood, 99 6
B. Godeau, S. Chevret, B. Varet, F. Lefrère, J. Zini, F. Bassompierre, S. Cheze, E. Legouffe, C. Hulin, M. Grange, O. Fain, P. Bierling (2002)
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trialThe Lancet, 359
K. Fujimura, Y. Harada, T. Fujimoto, A. Kuramoto, Y. Ikeda, J. Akatsuka, K. Dan, M. Omine, H. Mizoguchi (2002)
Nationwide Study of Idiopathic Thrombocytopenic Purpura in Pregnant Women and the Clinical Influence on NeonatesInternational Journal of Hematology, 75
B. Godeau, J. Durand, F. Roudot-thoraval, Anne Tennezé, É. Oksenhendler, G. Kaplanski, A. Schaeffer, P. Bierling (1997)
Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 casesBritish Journal of Haematology, 97
M. Warner, J. Moore, T. Warkentin, A. Santos, J. Kelton (1999)
A prospective study of protein‐specific assays used to investigate idiopathic thrombocytopenic purpuraBritish Journal of Haematology, 104
Mei-Tzu Chang, Peggy Nakagawa, Shirley Williams, M. Schwartz, K. Imfeld, J. Buzby, D. Nugent (2003)
Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.Blood, 102 3
Idiopathic thrombocytopenic purpura (ITP) is a common hematologic disorder manifested by immune-mediated thrombocytopenia. The diagnosis remains one of exclusion, after other thrombocytopenic disorders are ruled out based on history, physical examination, and laboratory evaluation. The goal of treatment is to raise the platelet count into a hemostatically safe range. The disorder is usually chronic, although there is considerable variation in the clinical course and most patients eventually attain safe platelet counts off treatment. However, a subset of patients has severe disease refractory to all treatment modalities, which is associated with considerable morbidity and mortality. This article focuses on the management of primary ITP in adults. We discuss criteria for treatment, the roles of splenectomy and other treatment options along with their side effects, and the management of ITP during pregnancy.
Annual Review of Medicine – Annual Reviews
Published: Feb 18, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.